• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用人角膜药敏水平对环丙沙星和氧氟沙星进行比较。

Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels.

作者信息

Kowalski R P, Karenchak L M, Gordon Y J

机构信息

The University of Pittsburgh and Medical Center, Pennsylvania 15213, USA.

出版信息

Cornea. 1998 May;17(3):282-7.

PMID:9603384
Abstract

PURPOSE

We compared the in vitro susceptibility of gram-positive bacteria to ciprofloxacin and ofloxacin using human corneal susceptibility levels.

METHODS

The concentrations of ciprofloxacin and ofloxacin that can be attained in 99% of human corneas (Cornea99) after topical administration were calculated statistically from reported data. The minimal inhibitory concentrations (MICs) were determined for 95 corneal isolates of gram-positive bacteria (51 Staphylococcus aureus, 16 Streptococcus pneumoniae, 16 Streptococcus viridans group, and 12 coagulase-negative staphylococci). Susceptibility was interpreted by comparing the MICs with the respective Cornea99 for each antibiotic. Time-kill studies of representative gram-positive bacteria were tested using the Cornea99 and the maximal corneal concentrations reported for ciprofloxacin and ofloxacin.

RESULTS

The Cornea99 of ciprofloxacin and ofloxacin were calculated to be 3.57 microg/ml (n = 22) and 2.22 microg/ml (n = 20), respectively. The reported mean corneal concentrations of ciprofloxacin (6.90 +/- 6.20 microg/ml) and ofloxacin (5.71 +/- 6.15 microg/ml) were comparable (p = 0.54). All gram-positive bacteria were equally susceptible to ciprofloxacin and ofloxacin (p = 0.54) based on the Cornea99. The time-kill studies determined that 8-24 h were required for both ciprofloxacin and ofloxacin to reach bactericidal levels.

CONCLUSION

Ciprofloxacin and ofloxacin demonstrated comparable penetration into the cornea and provided equivalent in vitro efficacy against representative gram-positive bacteria. Time-kill studies indicated that 8-24 h of continual corneal concentrations of ciprofloxacin and ofloxacin were necessary in this study to reduce susceptible gram-positive bacteria by 99.9%.

摘要

目的

我们使用人角膜药敏水平比较革兰氏阳性菌对环丙沙星和氧氟沙星的体外敏感性。

方法

根据报道的数据,通过统计学方法计算局部给药后99%人角膜(角膜99)中可达到的环丙沙星和氧氟沙星浓度。测定了95株革兰氏阳性菌角膜分离株(51株金黄色葡萄球菌、16株肺炎链球菌、16株草绿色链球菌群和12株凝固酶阴性葡萄球菌)的最低抑菌浓度(MIC)。通过将每种抗生素的MIC与各自的角膜99进行比较来解释药敏情况。使用角膜99以及报道的环丙沙星和氧氟沙星的最大角膜浓度对代表性革兰氏阳性菌进行了时间-杀菌研究。

结果

环丙沙星和氧氟沙星的角膜99分别计算为3.57微克/毫升(n = 22)和2.22微克/毫升(n = 20)。报道的环丙沙星(6.90±6.20微克/毫升)和氧氟沙星(5.71±6.15微克/毫升)的平均角膜浓度具有可比性(p = 0.54)。基于角膜99,所有革兰氏阳性菌对环丙沙星和氧氟沙星的敏感性相同(p = 0.54)。时间-杀菌研究确定,环丙沙星和氧氟沙星均需要8 - 24小时才能达到杀菌水平。

结论

环丙沙星和氧氟沙星在角膜中的穿透性相当,对代表性革兰氏阳性菌具有同等的体外疗效。时间-杀菌研究表明,在本研究中,环丙沙星和氧氟沙星持续8 - 24小时的角膜浓度对于将敏感革兰氏阳性菌减少99.9%是必要的。

相似文献

1
Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels.使用人角膜药敏水平对环丙沙星和氧氟沙星进行比较。
Cornea. 1998 May;17(3):282-7.
2
Treatment of experimental bacterial keratitis with topical trovafloxacin.局部用曲伐沙星治疗实验性细菌性角膜炎。
Arch Ophthalmol. 2004 Jan;122(1):65-9. doi: 10.1001/archopht.122.1.65.
3
Susceptibility of corneal and conjunctival pathogens to ciprofloxacin.角膜和结膜病原体对环丙沙星的敏感性。
Cornea. 1996 Jan;15(1):66-71.
4
Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery.白内障手术犬局部给药后环丙沙星和氧氟沙星的房水浓度
Vet Ophthalmol. 2005 May-Jun;8(3):181-7. doi: 10.1111/j.1463-5224.2005.00368.x.
5
In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.左氧氟沙星对凝固酶阳性和阴性葡萄球菌的体外活性。
Drugs Exp Clin Res. 2001;27(3):107-11.
6
[In vitro fluoroquinolone resistance in ocular bacterial isolates].[眼部细菌分离株的体外氟喹诺酮耐药性]
Zhonghua Yan Ke Za Zhi. 2003 Mar;39(3):163-6.
7
An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.一项使用金黄色葡萄球菌和铜绿假单胞菌角膜炎分离株对左氧氟沙星、环丙沙星和氧氟沙星进行的体外耐药性研究。
Ophthalmology. 2001 Oct;108(10):1826-9. doi: 10.1016/s0161-6420(01)00724-2.
8
An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data.眼科医生解读抗生素敏感性和最低抑菌浓度数据指南
Ophthalmology. 2005 Nov;112(11):1987. doi: 10.1016/j.ophtha.2005.06.025. Epub 2005 Sep 23.
9
In vitro ciprofloxacin resistance patterns of gram-positive bacteria isolated from clinical specimens in a teaching hospital in Saudi Arabia.沙特阿拉伯一家教学医院临床标本中分离出的革兰氏阳性菌的体外环丙沙星耐药模式。
J Ayub Med Coll Abbottabad. 2009 Jul-Sep;21(3):54-6.
10
In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.
Am J Med. 1987 Apr 27;82(4A):33-9.

引用本文的文献

1
Anti-Infective Treatment and Resistance Is Rarely Problematic with Eye Infections.抗微生物治疗及耐药性在眼部感染中很少成为问题。
Antibiotics (Basel). 2022 Feb 6;11(2):204. doi: 10.3390/antibiotics11020204.
2
Microbial Keratitis at an Urban Public Hospital: A 10-Year Update.城市公立医院的微生物性角膜炎:十年回顾
J Clin Exp Ophthalmol. 2015 Dec;6(6). doi: 10.4172/2155-9570.1000498. Epub 2015 Nov 30.
3
Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis.加替沙星滴眼液治疗细菌性结膜炎的临床应用
Clin Ophthalmol. 2011;5:495-502. doi: 10.2147/OPTH.S13778. Epub 2011 Apr 18.
4
Fluoroquinolones: place in ocular therapy.氟喹诺酮类药物:在眼部治疗中的应用
Drugs. 2001;61(6):747-61. doi: 10.2165/00003495-200161060-00004.